Hope4Kids is a joint action bringing together 23 European countries to improve and harmonise paediatric palliative care through evidence-based guidelines, training, pilot programmes, and policy collaboration, ensuring equal, holistic care for all children with life‑limiting conditions.
This 2025 updated CAYA policy brief publication outlines key recommendations to improve care and outcomes for young cancer patients.
.png?width=3072&format=webp)
The BSPHO Symposium 2025 was held on 28 November at the Provinciehuis Leuven. See the event highlights!
.png?width=3072&format=webp)
This Scientific Meeting centred on implementing paediatric cancer guidelines, with sessions on fertility preservation, ATRT, and JMML care.
.png?width=3072&format=webp)
BSPHO joined Run To Kick 2025, which raised over €2.3M to fight childhood cancer and support vital research.
.png?width=3072&format=webp)
HEM-iSMART trial studies tailored drug combinations for pediatric T-ALL/T-LBL based on specific tumor alterations.
.png?width=3072&format=webp)
BSPHO coordinates the evacuation of four young cancer patients from Gaza, continuing its humanitarian support in conflict zones.
.png?width=3072&format=webp)
BSPHO welcomes new board, thanks past members, and begins a new leadership chapter to advance paediatric haemato-oncology care.
The BSPHO Clinical Trial Day 2025 was held on 20 June at the Park Inn Hotel in Leuven. Read the event highlights.
.png?width=3072&format=webp)
New publication by Belgian Cancer Registry: “Cancer in Adolescents and Young Adults – Belgium 2004-2022” released, highlighting key insights.
.png?width=3072&format=webp)
A new trial launched in Belgium for pediatric AML patients, integrating Europe’s frontline treatment approach.
.png?width=3072&format=webp)
The BSPHO Scientific Meeting on 21 February featured key insights into pediatric haemato-oncology research. See the topics discussed.
.png?width=3072&format=webp)
The iLTB trial aims to optimize treatment decisions for relapsed/refractory leukemia/lymphoma patients through international collaboration and molecular profiling.
The SIOPE ATRT01 trial launched in August 2024, aims to improve treatment efficacy and neurocognitive outcomes for children with Atypical Teratoid/Rhabdoid Tumours (ATRT).
.png?width=3072&format=webp)
The ML-DS 2018 trial aims to improve outcomes for Down syndrome patients with myeloid leukemia (ML) or myelodysplastic syndrome (MDS).
.png?width=3072&format=webp)
The Symposium on 22 November featured key insights into novel therapies and new techniques in pediatric oncology. See topics discussed and event photos.
PRINCESS, a multicentre clinical trial open since 9 October 2024 in Belgium, aims to assess fertility and ovarian function in survivors of childhood cancer aged 18 years or older.
BSPHO's new vision focuses on research support, clinical trials, advocacy, outreach, and greater member involvement in pediatric cancer care.
BSPHO awards up to 1,100€ scholarships to young doctors/researchers. See eligibility and application details below.
A new trial for infants (<1 year) with KMT2A‐rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia launched in Belgium.
The CAYA policy brief publication outlines key recommendations to improve care and outcomes for young cancer patients.
.png?width=3072&format=webp)
BSPHO coordinated the care of the young gazan patients from Gaza by paediatric oncology centres across the country.
The BSPHO Clinical Trial Day 2024 was held on 21 June at the Park Inn Hotel in Leuven. Read the event highlights.
New booklet by BAYER: 'Detective Didi & Sidekick' - Helping Kids Understand Cancer.
The Belgian Cancer Registry presents its latest publication 'Cancer in children and adolescents in Belgium 2004-2020'.
We are pleased to share Neuroblastoma educational materials developed by the working groups (WG) for patients and their families. Learn more about it and find the material here!
BSPHO coordinated the arrival of 4 Ukrainian children with cancer in Belgium to ensure the best care for patients and their families.